Belfast, United Kingdom

Michael A McKervey


Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Belfast BT9 6JN, GB (1992)
  • Belfast BT9 6JN, Northern Ireland, GB (1997)
  • Belfast, GB (1993 - 2010)

Company Filing History:


Years Active: 1992-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael A McKervey: Innovator in Pharmaceutical Chemistry

Introduction

Michael A McKervey is a distinguished inventor based in Belfast, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 5 patents to his name, McKervey's work has the potential to impact various therapeutic areas.

Latest Patents

One of McKervey's latest patents involves selective glucocorticoid receptor agonists. This invention is directed to a method for treating inflammatory conditions, haematological malignancies, immunosuppression, and preventing or treating transplant rejection in humans and other animals. The method comprises administering a compound with specific structural formulas, which include various derivatives and pro-drugs. Additionally, he has worked on chromoionophores and optical sensors containing them, showcasing his versatility in the field.

Career Highlights

Throughout his career, McKervey has been associated with notable companies, including Loctite (Ireland) Limited. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical technologies.

Collaborations

McKervey has collaborated with esteemed colleagues such as Stephen J Harris and Dermot Diamond. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Michael A McKervey is a prominent figure in the realm of pharmaceutical innovation. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…